U.S. flag

An official website of the United States government

NM_000180.4(GUCY2D):c.2383C>T (p.Arg795Trp) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 29, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001383052.8

Allele description [Variation Report for NM_000180.4(GUCY2D):c.2383C>T (p.Arg795Trp)]

NM_000180.4(GUCY2D):c.2383C>T (p.Arg795Trp)

Gene:
GUCY2D:guanylate cyclase 2D, retinal [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000180.4(GUCY2D):c.2383C>T (p.Arg795Trp)
HGVS:
  • NC_000017.11:g.8013999C>T
  • NG_009092.1:g.16330C>T
  • NM_000180.4:c.2383C>TMANE SELECT
  • NP_000171.1:p.Arg795Trp
  • NC_000017.10:g.7917317C>T
Protein change:
R795W
Links:
dbSNP: rs765910207
NCBI 1000 Genomes Browser:
rs765910207
Molecular consequence:
  • NM_000180.4:c.2383C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cone-rod dystrophy 6 (CORD6)
Synonyms:
RETINAL CONE DYSTROPHY 2; Cone dystrophy progressive
Identifiers:
MONDO: MONDO:0011143; MedGen: C1866293; Orphanet: 1872; OMIM: 601777
Name:
Leber congenital amaurosis 1 (LCA1)
Synonyms:
AMAUROSIS CONGENITA OF LEBER I; RETINAL BLINDNESS, CONGENITAL; Congenital absence of the rods and cones; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008764; MedGen: C2931258; Orphanet: 65; OMIM: 204000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001582070Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 29, 2024)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis.

Pasadhika S, Fishman GA, Stone EM, Lindeman M, Zelkha R, Lopez I, Koenekoop RK, Shahidi M.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2608-14. doi: 10.1167/iovs.09-3734. Epub 2009 Dec 3.

PubMed [citation]
PMID:
19959640
PMCID:
PMC2868490

The genetic profile of Leber congenital amaurosis in an Australian cohort.

Thompson JA, De Roach JN, McLaren TL, Montgomery HE, Hoffmann LH, Campbell IR, Chen FK, Mackey DA, Lamey TM.

Mol Genet Genomic Med. 2017 Nov;5(6):652-667. doi: 10.1002/mgg3.321. Epub 2017 Aug 22.

PubMed [citation]
PMID:
29178642
PMCID:
PMC5702575
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001582070.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 795 of the GUCY2D protein (p.Arg795Trp). This variant is present in population databases (rs765910207, gnomAD 0.0009%). This missense change has been observed in individual(s) with Leber congenital amaurosis (PMID: 19959640, 29178642; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1070768). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GUCY2D protein function with a positive predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Arg795 amino acid residue in GUCY2D. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17724218, 26352687). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 11, 2025